Shilpa Bhupathiraju, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diet | 44 | 2024 | 8075 | 2.690 |
Why?
|
Metabolomics | 13 | 2024 | 1659 | 2.630 |
Why?
|
Diabetes Mellitus, Type 2 | 35 | 2024 | 12149 | 2.580 |
Why?
|
Diet, Mediterranean | 8 | 2023 | 740 | 1.380 |
Why?
|
Saliva | 2 | 2024 | 828 | 1.340 |
Why?
|
Cardiovascular Diseases | 24 | 2024 | 15502 | 1.330 |
Why?
|
Eggs | 2 | 2020 | 182 | 1.280 |
Why?
|
Puerto Rico | 14 | 2024 | 376 | 1.240 |
Why?
|
Feeding Behavior | 12 | 2021 | 3188 | 1.220 |
Why?
|
Nurses | 11 | 2021 | 2478 | 1.180 |
Why?
|
Diet, Vegetarian | 6 | 2022 | 180 | 1.130 |
Why?
|
Menopause | 4 | 2018 | 1646 | 1.100 |
Why?
|
Fruit | 10 | 2021 | 1160 | 1.090 |
Why?
|
Estrogens, Conjugated (USP) | 2 | 2018 | 276 | 1.090 |
Why?
|
Vegetables | 9 | 2024 | 1195 | 1.070 |
Why?
|
Atherosclerosis | 4 | 2024 | 3407 | 1.030 |
Why?
|
Life Style | 11 | 2022 | 3917 | 0.940 |
Why?
|
Amino Acids, Aromatic | 1 | 2024 | 36 | 0.940 |
Why?
|
Methylamines | 1 | 2024 | 136 | 0.850 |
Why?
|
Nutritional Status | 9 | 2024 | 1615 | 0.840 |
Why?
|
Hyperinsulinism | 2 | 2022 | 400 | 0.820 |
Why?
|
Nuts | 3 | 2021 | 264 | 0.800 |
Why?
|
Coffee | 7 | 2022 | 593 | 0.800 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2024 | 269 | 0.780 |
Why?
|
Nutritive Value | 5 | 2021 | 350 | 0.770 |
Why?
|
Prediabetic State | 2 | 2024 | 545 | 0.740 |
Why?
|
Periodontal Diseases | 1 | 2024 | 451 | 0.720 |
Why?
|
Dietary Carbohydrates | 4 | 2020 | 891 | 0.700 |
Why?
|
Obesity | 13 | 2024 | 12947 | 0.680 |
Why?
|
Postmenopause | 7 | 2024 | 2513 | 0.650 |
Why?
|
Proteomics | 2 | 2023 | 3848 | 0.640 |
Why?
|
Estrogen Replacement Therapy | 3 | 2022 | 1208 | 0.590 |
Why?
|
Dyslipidemias | 2 | 2024 | 868 | 0.580 |
Why?
|
Specimen Handling | 1 | 2022 | 702 | 0.580 |
Why?
|
Disease Progression | 3 | 2024 | 13510 | 0.570 |
Why?
|
Follow-Up Studies | 31 | 2024 | 39106 | 0.560 |
Why?
|
Coronary Disease | 7 | 2022 | 5914 | 0.550 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2017 | 155 | 0.550 |
Why?
|
Prospective Studies | 39 | 2024 | 54423 | 0.550 |
Why?
|
Longitudinal Studies | 12 | 2024 | 14608 | 0.530 |
Why?
|
Nutrition Assessment | 7 | 2021 | 728 | 0.530 |
Why?
|
Cross-Sectional Studies | 21 | 2024 | 26129 | 0.530 |
Why?
|
Dietary Proteins | 3 | 2021 | 952 | 0.530 |
Why?
|
Dietary Fats | 3 | 2021 | 1995 | 0.510 |
Why?
|
Hip Fractures | 1 | 2024 | 988 | 0.500 |
Why?
|
Middle Aged | 65 | 2024 | 220921 | 0.480 |
Why?
|
Anthropometry | 5 | 2021 | 1349 | 0.480 |
Why?
|
Risk Factors | 46 | 2023 | 74213 | 0.480 |
Why?
|
Hot Flashes | 1 | 2017 | 330 | 0.470 |
Why?
|
Carnitine | 3 | 2024 | 252 | 0.460 |
Why?
|
Overweight | 4 | 2024 | 2417 | 0.460 |
Why?
|
Hormone Replacement Therapy | 2 | 2017 | 751 | 0.460 |
Why?
|
Humans | 113 | 2024 | 761596 | 0.460 |
Why?
|
Beverages | 5 | 2024 | 821 | 0.450 |
Why?
|
Contraceptives, Oral | 1 | 2016 | 554 | 0.450 |
Why?
|
Drinking Behavior | 1 | 2014 | 103 | 0.440 |
Why?
|
United States | 33 | 2024 | 72340 | 0.430 |
Why?
|
Energy Intake | 7 | 2021 | 2134 | 0.430 |
Why?
|
Female | 75 | 2024 | 392705 | 0.430 |
Why?
|
Boston | 12 | 2024 | 9327 | 0.420 |
Why?
|
Glycemic Index | 2 | 2017 | 396 | 0.420 |
Why?
|
Cohort Studies | 21 | 2024 | 41495 | 0.410 |
Why?
|
Abdominal Fat | 2 | 2011 | 221 | 0.400 |
Why?
|
Body Mass Index | 10 | 2018 | 12953 | 0.390 |
Why?
|
Bone Density | 4 | 2013 | 3551 | 0.390 |
Why?
|
Forecasting | 2 | 2017 | 2928 | 0.380 |
Why?
|
Metabolic Diseases | 1 | 2018 | 683 | 0.380 |
Why?
|
Caffeine | 2 | 2014 | 700 | 0.380 |
Why?
|
Obesity, Abdominal | 3 | 2021 | 374 | 0.380 |
Why?
|
Aged | 42 | 2024 | 169310 | 0.370 |
Why?
|
Diabetes Mellitus | 3 | 2020 | 5841 | 0.370 |
Why?
|
Insulin Resistance | 2 | 2024 | 3964 | 0.360 |
Why?
|
Cause of Death | 7 | 2023 | 3683 | 0.360 |
Why?
|
Bone and Bones | 2 | 2013 | 2568 | 0.350 |
Why?
|
Pesticide Residues | 2 | 2021 | 95 | 0.340 |
Why?
|
Adult | 44 | 2024 | 221210 | 0.340 |
Why?
|
Diet Surveys | 4 | 2021 | 1162 | 0.330 |
Why?
|
Diabetes Complications | 1 | 2016 | 1315 | 0.330 |
Why?
|
Patient Compliance | 4 | 2015 | 2690 | 0.330 |
Why?
|
Male | 53 | 2024 | 360846 | 0.320 |
Why?
|
Incidence | 13 | 2024 | 21355 | 0.320 |
Why?
|
Eating | 4 | 2023 | 1539 | 0.320 |
Why?
|
Blood Glucose | 5 | 2024 | 6391 | 0.310 |
Why?
|
Malnutrition | 4 | 2021 | 645 | 0.300 |
Why?
|
Bone Resorption | 1 | 2011 | 723 | 0.290 |
Why?
|
Folic Acid | 3 | 2023 | 1323 | 0.280 |
Why?
|
Sweetening Agents | 4 | 2024 | 290 | 0.280 |
Why?
|
Micronutrients | 4 | 2021 | 382 | 0.270 |
Why?
|
Epidemiologic Studies | 2 | 2022 | 675 | 0.260 |
Why?
|
Chronic Disease | 2 | 2018 | 9319 | 0.260 |
Why?
|
Risk | 8 | 2021 | 9610 | 0.250 |
Why?
|
India | 3 | 2021 | 2348 | 0.240 |
Why?
|
Meglutol | 1 | 2024 | 5 | 0.230 |
Why?
|
Proportional Hazards Models | 10 | 2020 | 12463 | 0.230 |
Why?
|
Homocysteine | 1 | 2007 | 638 | 0.230 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2007 | 396 | 0.230 |
Why?
|
Soy Foods | 1 | 2024 | 44 | 0.230 |
Why?
|
Betaine | 1 | 2024 | 90 | 0.230 |
Why?
|
American Heart Association | 3 | 2013 | 1039 | 0.220 |
Why?
|
Riboflavin | 1 | 2023 | 107 | 0.210 |
Why?
|
C-Reactive Protein | 6 | 2016 | 3826 | 0.210 |
Why?
|
Nutrition Surveys | 5 | 2024 | 1733 | 0.210 |
Why?
|
Smoking | 2 | 2018 | 9053 | 0.200 |
Why?
|
Diabetes, Gestational | 2 | 2022 | 1248 | 0.200 |
Why?
|
Mortality | 3 | 2020 | 2902 | 0.200 |
Why?
|
Choline | 1 | 2024 | 515 | 0.200 |
Why?
|
Overnutrition | 1 | 2021 | 25 | 0.200 |
Why?
|
Hemoglobins | 3 | 2021 | 1526 | 0.190 |
Why?
|
Dietary Fiber | 3 | 2017 | 759 | 0.190 |
Why?
|
Plants | 2 | 2021 | 327 | 0.190 |
Why?
|
Waist Circumference | 3 | 2021 | 935 | 0.190 |
Why?
|
Risk Assessment | 4 | 2020 | 23996 | 0.190 |
Why?
|
Glucose | 2 | 2024 | 4347 | 0.190 |
Why?
|
Asia | 2 | 2020 | 619 | 0.190 |
Why?
|
Inflammation Mediators | 3 | 2020 | 1886 | 0.190 |
Why?
|
Juglans | 1 | 2021 | 45 | 0.180 |
Why?
|
Diet Therapy | 1 | 2021 | 151 | 0.170 |
Why?
|
Adiposity | 3 | 2023 | 1879 | 0.160 |
Why?
|
Rural Population | 4 | 2021 | 2287 | 0.160 |
Why?
|
Stroke | 3 | 2022 | 9758 | 0.160 |
Why?
|
Food | 2 | 2021 | 774 | 0.160 |
Why?
|
Administration, Intravaginal | 1 | 2018 | 150 | 0.160 |
Why?
|
Health Status | 2 | 2021 | 4077 | 0.150 |
Why?
|
Food Contamination | 1 | 2019 | 191 | 0.150 |
Why?
|
Reproducibility of Results | 3 | 2023 | 20100 | 0.150 |
Why?
|
Myocardial Infarction | 1 | 2018 | 11461 | 0.150 |
Why?
|
Inflammation | 4 | 2020 | 10774 | 0.150 |
Why?
|
Guidelines as Topic | 3 | 2013 | 1386 | 0.140 |
Why?
|
Women's Health | 2 | 2017 | 2065 | 0.140 |
Why?
|
Risk Reduction Behavior | 2 | 2021 | 1112 | 0.140 |
Why?
|
Communicable Disease Control | 1 | 2023 | 846 | 0.140 |
Why?
|
Food Preferences | 1 | 2020 | 398 | 0.140 |
Why?
|
Adiponectin | 1 | 2022 | 1113 | 0.140 |
Why?
|
Allostasis | 2 | 2015 | 72 | 0.130 |
Why?
|
Cholesterol, LDL | 2 | 2022 | 2382 | 0.130 |
Why?
|
Europe | 2 | 2020 | 3420 | 0.130 |
Why?
|
Multivariate Analysis | 4 | 2018 | 12059 | 0.130 |
Why?
|
State Medicine | 1 | 2017 | 216 | 0.130 |
Why?
|
Starch | 1 | 2015 | 79 | 0.130 |
Why?
|
Mexican Americans | 1 | 2016 | 167 | 0.120 |
Why?
|
Mexico | 3 | 2021 | 764 | 0.120 |
Why?
|
Body Weight | 3 | 2021 | 4618 | 0.120 |
Why?
|
Magnesium | 1 | 2017 | 804 | 0.110 |
Why?
|
Neurodegenerative Diseases | 1 | 2023 | 1088 | 0.110 |
Why?
|
Citrus | 1 | 2013 | 49 | 0.110 |
Why?
|
Leptin | 1 | 2021 | 1597 | 0.110 |
Why?
|
Dietary Sucrose | 1 | 2015 | 243 | 0.110 |
Why?
|
Neoplasms | 2 | 2019 | 22173 | 0.110 |
Why?
|
Ferritins | 3 | 2021 | 598 | 0.110 |
Why?
|
Young Adult | 9 | 2021 | 59260 | 0.110 |
Why?
|
Plant Leaves | 1 | 2013 | 150 | 0.110 |
Why?
|
Osteoporosis | 2 | 2013 | 1606 | 0.100 |
Why?
|
Dietary Supplements | 2 | 2023 | 3415 | 0.100 |
Why?
|
Energy Metabolism | 2 | 2021 | 2882 | 0.100 |
Why?
|
Primary Prevention | 1 | 2020 | 1186 | 0.100 |
Why?
|
Vitamin D Deficiency | 1 | 2022 | 1388 | 0.100 |
Why?
|
Health Surveys | 2 | 2020 | 4061 | 0.100 |
Why?
|
Autonomic Nervous System | 1 | 2017 | 703 | 0.100 |
Why?
|
Comparative Effectiveness Research | 1 | 2017 | 709 | 0.100 |
Why?
|
beta Carotene | 1 | 2013 | 523 | 0.100 |
Why?
|
Anemia | 1 | 2021 | 1509 | 0.100 |
Why?
|
Carbonated Beverages | 1 | 2012 | 210 | 0.090 |
Why?
|
Weight Gain | 1 | 2021 | 2348 | 0.090 |
Why?
|
Socioeconomic Factors | 4 | 2021 | 7828 | 0.090 |
Why?
|
Tea | 1 | 2012 | 288 | 0.090 |
Why?
|
Self Report | 3 | 2020 | 3725 | 0.090 |
Why?
|
Health Personnel | 2 | 2015 | 3335 | 0.090 |
Why?
|
Ascorbic Acid | 1 | 2013 | 655 | 0.090 |
Why?
|
Diet Records | 2 | 2021 | 427 | 0.090 |
Why?
|
C-Peptide | 2 | 2022 | 440 | 0.080 |
Why?
|
Adipose Tissue | 1 | 2021 | 3313 | 0.080 |
Why?
|
Acculturation | 1 | 2011 | 178 | 0.080 |
Why?
|
Time Factors | 4 | 2020 | 39969 | 0.080 |
Why?
|
Prevalence | 2 | 2024 | 15733 | 0.080 |
Why?
|
Models, Statistical | 2 | 2021 | 5079 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1866 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2578 | 0.080 |
Why?
|
Arm | 2 | 2021 | 589 | 0.080 |
Why?
|
Motor Activity | 3 | 2015 | 2715 | 0.080 |
Why?
|
Iron | 1 | 2016 | 1793 | 0.080 |
Why?
|
Bone Diseases, Metabolic | 1 | 2011 | 409 | 0.070 |
Why?
|
Software | 1 | 2021 | 4434 | 0.070 |
Why?
|
Adolescent | 8 | 2021 | 88326 | 0.070 |
Why?
|
Absorptiometry, Photon | 1 | 2013 | 1738 | 0.070 |
Why?
|
Acute-Phase Proteins | 1 | 2008 | 250 | 0.070 |
Why?
|
Health Behavior | 2 | 2015 | 2644 | 0.070 |
Why?
|
Sleep | 3 | 2022 | 4768 | 0.070 |
Why?
|
Survival Analysis | 1 | 2019 | 10090 | 0.070 |
Why?
|
North America | 2 | 2023 | 1276 | 0.070 |
Why?
|
Lumbar Vertebrae | 2 | 2013 | 1879 | 0.070 |
Why?
|
Public Health | 1 | 2019 | 2669 | 0.070 |
Why?
|
Alcohol Drinking | 1 | 2019 | 4028 | 0.060 |
Why?
|
Mental Recall | 2 | 2021 | 1221 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2024 | 58984 | 0.060 |
Why?
|
Massachusetts | 1 | 2017 | 8833 | 0.060 |
Why?
|
Depression | 1 | 2024 | 8126 | 0.060 |
Why?
|
Regression Analysis | 2 | 2019 | 6345 | 0.060 |
Why?
|
Indonesia | 1 | 2024 | 128 | 0.060 |
Why?
|
China | 2 | 2021 | 2374 | 0.050 |
Why?
|
Placebos | 1 | 2007 | 1667 | 0.050 |
Why?
|
Sex Factors | 2 | 2020 | 10554 | 0.050 |
Why?
|
Pandemics | 1 | 2022 | 8656 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18399 | 0.050 |
Why?
|
Cognition | 1 | 2020 | 6992 | 0.050 |
Why?
|
Logistic Models | 2 | 2013 | 13255 | 0.050 |
Why?
|
Carbohydrates | 1 | 2024 | 390 | 0.050 |
Why?
|
Uric Acid | 1 | 2007 | 807 | 0.050 |
Why?
|
Glutamates | 1 | 2021 | 389 | 0.040 |
Why?
|
Ethiopia | 1 | 2021 | 464 | 0.040 |
Why?
|
Hypothalamic Diseases | 1 | 2020 | 134 | 0.040 |
Why?
|
Africa South of the Sahara | 1 | 2021 | 744 | 0.040 |
Why?
|
Health Promotion | 1 | 2011 | 2214 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17904 | 0.040 |
Why?
|
Acyltransferases | 1 | 2020 | 305 | 0.040 |
Why?
|
Lipoproteins, HDL | 1 | 2022 | 676 | 0.040 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2020 | 269 | 0.040 |
Why?
|
Interleukin-6 | 3 | 2015 | 3208 | 0.040 |
Why?
|
Purines | 1 | 2021 | 607 | 0.040 |
Why?
|
Poultry | 1 | 2016 | 80 | 0.030 |
Why?
|
Animals | 3 | 2024 | 168475 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2015 | 4352 | 0.030 |
Why?
|
New Zealand | 1 | 2016 | 358 | 0.030 |
Why?
|
Publication Bias | 1 | 2016 | 160 | 0.030 |
Why?
|
Fasting | 1 | 2021 | 1603 | 0.030 |
Why?
|
Receptors, Transferrin | 1 | 2016 | 291 | 0.030 |
Why?
|
Estrogens | 1 | 2022 | 1522 | 0.030 |
Why?
|
Linear Models | 2 | 2016 | 5872 | 0.030 |
Why?
|
Amino Acids | 1 | 2021 | 1718 | 0.030 |
Why?
|
Educational Status | 1 | 2021 | 2522 | 0.030 |
Why?
|
Vitamins | 1 | 2022 | 1635 | 0.030 |
Why?
|
Interleukin-1beta | 2 | 2010 | 999 | 0.030 |
Why?
|
Urban Population | 1 | 2021 | 2036 | 0.030 |
Why?
|
Sexual Behavior | 1 | 2023 | 2180 | 0.030 |
Why?
|
Cholesterol | 1 | 2022 | 2905 | 0.030 |
Why?
|
Metabolome | 1 | 2020 | 989 | 0.030 |
Why?
|
Double-Blind Method | 1 | 2007 | 12341 | 0.030 |
Why?
|
Aging | 1 | 2012 | 8710 | 0.030 |
Why?
|
Exercise | 2 | 2023 | 5890 | 0.030 |
Why?
|
Income | 1 | 2021 | 1877 | 0.030 |
Why?
|
Australia | 1 | 2016 | 1250 | 0.030 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2016 | 369 | 0.030 |
Why?
|
Data Collection | 1 | 2021 | 3322 | 0.030 |
Why?
|
Nutrition Policy | 1 | 2015 | 471 | 0.020 |
Why?
|
Research Design | 1 | 2007 | 6180 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2018 | 21019 | 0.020 |
Why?
|
Nonlinear Dynamics | 1 | 2013 | 492 | 0.020 |
Why?
|
Pregnancy | 2 | 2022 | 29890 | 0.020 |
Why?
|
Lipids | 1 | 2021 | 3341 | 0.020 |
Why?
|
Urban Health | 1 | 2012 | 532 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 29629 | 0.020 |
Why?
|
Algorithms | 2 | 2021 | 14033 | 0.020 |
Why?
|
Vitamin D | 1 | 2022 | 3303 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2013 | 1814 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2020 | 7054 | 0.020 |
Why?
|
Swine | 1 | 2016 | 5915 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2010 | 1596 | 0.020 |
Why?
|
Social Support | 1 | 2015 | 2172 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5429 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2012 | 2358 | 0.020 |
Why?
|
Phenotype | 1 | 2023 | 16592 | 0.020 |
Why?
|
Fibrinogen | 1 | 2008 | 888 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 22176 | 0.010 |
Why?
|
Femur | 1 | 2010 | 1307 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15843 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10766 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12690 | 0.010 |
Why?
|
Hypertension | 1 | 2015 | 8540 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2008 | 10212 | 0.010 |
Why?
|
Heart Failure | 1 | 2013 | 11671 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2013 | 64685 | 0.000 |
Why?
|